
Eli Lilly Stock Slides on EPS Guidance—A Buying Opportunity or a Valuation Reset?
Eli Lilly’s (NYSE:LLY) stock faced a notable decline following the company’s announcement of a reduced profit forecast, despite delivering first-quarter results that surpassed Wall Street expectations. The pharmaceutical giant reported an adjusted earnings …